25
Views
4
CrossRef citations to date
0
Altmetric
Review

Achieving directed immunostimulating complexes incorporation

, , , , , & show all
Pages 395-403 | Published online: 09 Jan 2014

References

  • O'Hagan DT, Valiante NM. Recent advances in the discovery and delivery of vaccine adjuvants. Nat. Rev. Drug Discov.2, 727–735 (2003).
  • Barr IG, Sjölander A, Cox JC. ISCOMs and other saponin based adjuvants. Adv. Drug Deliv. Rev.32, 247–271 (1998).
  • Morein B, Bengtsson KL. Immunomodulation by iscoms, immune stimulating complexes. Methods19(1), 94–102 (1999).
  • Morein B, Hu K-F, Abusugra I. Current status and potential application of ISCOMs in veterinary medicine. Adv. Drug Deliv. Rev.56, 1367–1382 (2004).
  • Åkerblom L, Nara P, Dunlop N, Putney S, Morein B. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products. Biotechnol. Ther.4, 145–161 (1993).
  • Morein B, Ekström J, Lövgren K. Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms. J. Immunol. Methods128, 177–181 (1990).
  • Höglund S, Dalsgaard K, Lövgren K, Sundquist B, Osterhaus A, Morein B. ISCOMs and immunostimulation with viral antigens. In: Subcellular Biochemistry (Volume 15). Harris W (Ed.), Plenum, New York, USA 39–68 (1989).
  • Reid G. Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid. Vaccine10, 597–602 (1992).
  • Morein B, Lövgren K, B. R, Sjölander A, Villacrés-Eriksson M. Immunostimulating complexes clinical potential in vaccine development. Clin. Immunother.3, 461–475 (1995).
  • Larsson M, Lövgren K, Morein B. Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscoms. J. Immunol. Methods162, 257–260 (1993).
  • Andersson C, Sandberg L, Murby M, Sjölander A, Lövgren-Bengtsson K, Ståhl S. General expression vectors for production of hydrophobically tagged immunogens for direct iscom incorporation. J. Immunol. Methods222, 171–182 (1999).
  • Andersson C, Sandberg L, Wernérus H, Johansson M, Lövgren-Bengtsson K, Ståhl S. Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporation. J. Immunol. Methods238, 181–193 (2000).
  • Andersson C, Wikman M, Lövgren-Bengtsson K, Lundén A, Ståhl S. In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation. J. Immunol. Methods255, 135–148 (2001).
  • Andersson C, Wikman M, Lövgren-Bengtsson K, Ståhl S. Hydrophobic tagging of immunogens for iscom incorporation. In: Gene Cloning and Expression Technologies. Weiner MP, Lu Q (Eds.), Eaton Publishing, Westborough, MA, USA, 251–265 (2002).
  • Wikman M, Friedman M, Pinitkiatisakul S et al. Applying biotin–streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens. Biotechnol. Appl. Biochem.41, 163–174 (2005).
  • Wikman M, Friedman M, Pinitkiatisakul S et al. General strategies for efficient adjuvant incorporation of recombinant subunit immunogens. Vaccine23, 2331–2335 (2005).
  • Köhler K, Ljungquist C, Kondo A, Veide A, Nilsson B. Engineering proteins to enhance their partition coefficients in aqueous two-phase systems. Bio/Technology9, 642–646 (1991).
  • Hassinen C, Köhler K, Veide A. Polyethylene glycol-potassium phosphate aqueous two-phase systems. Insertion of short peptide units into a protein and its effects on partitioning. J. Chromatogr. A668, 121–128 (1994).
  • Sjölander A, Lövgren K, Ståhl S et al. High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. Vaccine9, 443–450 (1991).
  • Parente RA, Nir S, Szoka FCJ. pH-dependent fusion of phosphatidylcholine small vesicles. Induction by a synthetic amphipathic peptide. J. Biol. Chem.263, 4724–4730 (1988).
  • Nilsson B, Moks T, Jansson B et al. A synthetic IgG-binding domain based on staphylococcal protein A. Protein Engineering1, 107–113 (1987).
  • Sjölander A, Hansson M, Lövgren K, Wahlin B, Berzins K, Perlmann P. Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA. Parasite Immunol.15, 355–359 (1993).
  • Makrides SC. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev.60, 512–538 (1996).
  • Schneewind O, Fowler A, Faull KF. Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science268, 103–106 (1995).
  • Larsson M, Brundell E, Nordfors L, Hoog C, Uhlén M, Ståhl S. A general bacterial expression system for functional analysis of cDNA-encoded proteins. Protein Expr. Purif.7, 447–457 (1996).
  • Nilsson J, Nilsson P, Williams Y, Pettersson L, Uhlén M, Nygren P-Å. Competitive elution of protein A fusion proteins allows specific recovery under mild conditions. Eur. J. Biochem.224, 103–108 (1994).
  • Samuelsson E, Wadensten H, Hartmanis M, Moks T, Uhlén M. Facilitated in vitro refolding of human recombinant insulin-like growth factor I using a solubilizing fusion partner. Biotechnology (NY)9, 363–366 (1991).
  • Samuelsson E, Moks T, Nilsson B, Uhlén M. Enhanced in vitro refolding of insulin-like growth factor I using a solubilizing fusion partner. Biochemistry33, 4207–4211 (1994).
  • Libon C, Corvaia N, Haeuw JF et al. The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130–230 RSV-A protein. Vaccine17, 406–414 (1999).
  • Ghrayeb J, Inouye M. Nine amino acid residues at the NH2-terminal of lipoprotein are sufficient for its modification, processing, and localization in the outer membrane of Escherichia coli. J. Biol. Chem.259, 463–467 (1984).
  • Laukkanen M-L, Teeri TT, Keinänen K. Lipid-tagged antibodies: bacterial expression and characterization of lipoprotein-single-chain antibody fusion protein. Protein Engineering6, 449–454 (1993).
  • Hochuli E, Bannwarth W, Döbeli H, Gentz R, Stüber D. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Bio/Technology6, 1321–1325 (1988).
  • Ståhl S, Nilsson J, Hober S, Uhlén M, Nygren P-Å. Affinity fusions, gene expression. In: The Encyclopedia of Bioprocess Technology: Fermentation, Biocatalysis and Bioseparation. Flickinger MC, Drew SW (Eds), John Wiley and Sons Inc., New York, USA 49–63 (1999).
  • Burg JL, Perelman D, Kasper LH, Ware PL, Boothroyd JC. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol.141, 3584–3591 (1988).
  • Harning D, Spenter J, Metsis A, Vuust J, Petersen E. Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin. Diagn. Lab. Immunol.3, 355–357 (1996).
  • Savage D, Mattson G, Desai S, Nielander G, Morgensen S, Conklin E. Avidin-Biotin Chemistry: A Handbook. Pierce Chemical Company, Rockford, IL, USA (1992).
  • Schatz PJ. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Bio/Technology11, 1138–1143 (1993).
  • Nilsson J, Ståhl S, Lundeberg J, Uhlén M, Nygren P-Å. Affinity fusion strategies for detection, purification, and immobilization of recombinant proteins. Protein Expr. Purif.11, 1–16 (1997).
  • Howe DK, Crawford AC, Lindsay D, Sibley LD. The p29 and p35 immunodominant antigens of Neospora caninum tachyzoites are homologous to the family of surface antigens of Toxoplasma gondii. Infect. Immun.66, 5322–5328 (1998).
  • Pinitkiatisakul S, Mattsson JG, Wikman M et al. Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms. Vet. Parasitol.129, 25–34 (2005).
  • Saviranta P, Haavisto T, Rappu P, Karp M, Lövgren T. In vitro enzymatic biotinylation of recombinant fab fragments through a peptide acceptor tail. Bioconjug. Chem.9, 725–735 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.